logo of Swedish Orphan Biovitrum
logo of Swedish Orphan Biovitrum

Swedish Orphan Biovitrum Stock

Detail Data
Volume (24h): 110,275 shares
P/E Ratio: 24.34
Forward P/E: 17.89
EPS: 11.43 SEK
Forward EPS: 15.55 SEK
Number of Shares: 343,456,992 shares
Market Capitalization: 95,549,743,104.00 SEK

Dividend

Dividend Value
Dividend Amount According to our data, the company Swedish Orphan Biovitrum does not currently pay dividends.
Annual Yield %: -
Ex-dividend Date: -
5-Year Avg Yield %: -
Payout Ratio: -
Last Dividend Value: -
Last Dividend Date: -

Analyst Forecast

Most analysts have issued a buy recommendation for Swedish Orphan Biovitrum stock. The current number of analysts covering this company is 11. The highest target price is 383 SEK, while the lowest target price is 285 SEK. The median target valuation set by analysts is 360 SEK. These forecasts and recommendations provide insight into how analysts view the future stock performance of Swedish Orphan Biovitrum.
Analysts Recommendation
Issued Recommendation: According to our data, the recommendation for Swedish Orphan Biovitrum stock is: buy
Number of Analysts: 11
Highest Target Price: 383 SEK
Lowest Target Price: 285 SEK
Median Target Price: 360 SEK

Fundamental Indicators

Indicator Data
Total Revenue: 26,236,000,256.00 SEK
Net Income: 3,960,000,000.00 SEK
Price-to-Book (P/B): 2.45
PEG Ratio: /
Exchange: Stockholm
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Number of Employees: 1840
Country: Sweden

Where to Buy Swedish Orphan Biovitrum Stock?

You can purchase Swedish Orphan Biovitrum stock on the Stockholm under the ticker symbol: SOBI.ST. Several stock brokers or banks offer trading services for these stocks. Popular stock brokers like XTB and eToro allow you to buy real stocks and ETFs with zero or minimal commissions. Banks usually charge higher fees. Remember, investing in stocks involves risks, so it's important to carefully consider your financial situation and investment goals.

1

Real stocks and ETFs. Low minimum deposit, only 50 EUR. Option to copy trades. Advanced stock analysis and free education.

Trustpilot rating 4.4/5 Google play rating 4.2/5
Invest in Stocks with eToro
★★★★★ 5.0
2

Real stocks and ETFs + free demo account. Low fees + fast customer support. More than 5,200 instruments available for trading. Free training and education. Regular live streams on YouTube.

Trustpilot rating 3.6/5 Google play rating 4.5/5
Try Free Demo Account
★★★★☆ 4.8
Risk warning: Trading CFDs involves a high risk of financial loss. Between 51%-eToro -89% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

More Information on Swedish Orphan Biovitrum Stock

Indicator Value
Company Revenue: 26,236,000,256.00 SEK
EBITDA: 9,292,000,256.00 SEK - Positive EBITDA indicates profitable operations before interest, taxes, depreciation, and amortization.
Earnings Per Share: 11.43 SEK
Book Value Per Share: 113.64 SEK
Total Cash: 997,000,000.00 SEK
Total Cash per Share: 2.90 SEK
Total Debt: 14,021,000,192.00 SEK
Debt to Equity Ratio: 0.36
Quick Ratio 0.66
Current Ratio 0.98
Free Cash Flow 4,019,249,920.00 SEK
Operating Cash Flow 7,426,999,808.00 SEK
Gross Margins 78.30 %
EBITDA Margins 35.42 %
Operating Margins 22.41 %
Profit Margins 15.09 %
Return on Assets 5.0 %
Return on Equity 10.6 %
Earnings Growth (1 year) 8.2%
Revenue Growth (1 year) 3.3 %
Quarterly Earnings Year-over-Year Growth 9.4 %
Market Capitalization 95,549,743,104.00 SEK
Enterprise Value 108,100,935,680.00 SEK
EV/Revenue 4.12
EV/EBITDA 11.634
Float Shares 219,513,766 shares
Shares Outstanding 343,456,992 shares
Held Percent Insiders 0.10 %
Held Percent Institutions 73.43 %
Shares Short -
Shares Short Prior Month -
Date Short Interest -
Short Percentage of Total Shares -
Short Ratio -
Beta 0.23
Short Percentage of Float -
Implied Shares Outstanding 343,456,992

Frequently Asked Questions (FAQ)

According to our data, the company Swedish Orphan Biovitrum does not pay dividends yet, even in 2025.

Swedish Orphan Biovitrum shares are traded on the Stockholm stock exchange under the ticker: SOBI.ST. You can buy or trade them through a variety of stock brokers who provide real stock trading services.

According to our data, the recommendation for Swedish Orphan Biovitrum shares is from a total of 11 analysts. The average target price prediction is 360 SEK per share.

The total number of Swedish Orphan Biovitrum shares on the exchange is 343,456,992.00 shares, which at the current market capitalization gives the company a total valuation of 95,549,743,104.00 SEK.